Adalat® in the Asian Pacific Region

Nonfiction, Health & Well Being, Medical, Medical Science, Pharmacology, Specialties, Internal Medicine, Cardiology
Cover of the book Adalat® in the Asian Pacific Region by , Springer Berlin Heidelberg
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9783642749117
Publisher: Springer Berlin Heidelberg Publication: December 6, 2012
Imprint: Springer Language: English
Author:
ISBN: 9783642749117
Publisher: Springer Berlin Heidelberg
Publication: December 6, 2012
Imprint: Springer
Language: English

These are the proceedings of the third Asian Pacific Adalat Symposium. The first was held in Tokyo in 1982 and the second in Sydney in 1985. We were honoured that the late Dr. Sukaman and his colleagues were able to host this third symposium in Jakarta. This meeting was designed to contribute to and to promote international collaboration in cardiovascular research, and to help promote further knowledge and understanding about the treatment of vascular disease in the Asian Pacific area. Nifedipine was originally investigated in the mid-1960s by Prof. Fleckenstein. His first results showed this drug was a powerful calcium antagonist which altered excitation contraction. At this time, there was a rapid development of knowledge about the pathophysiology of ischaemic heart disease, and thus the important pharmacological work on calcium antagonists such as nifedipine paralleled and complimented the newer understanding of coronary physiology in man. In a short time most therapy was designed to reduce myocardial oxygen consumption and demand.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

These are the proceedings of the third Asian Pacific Adalat Symposium. The first was held in Tokyo in 1982 and the second in Sydney in 1985. We were honoured that the late Dr. Sukaman and his colleagues were able to host this third symposium in Jakarta. This meeting was designed to contribute to and to promote international collaboration in cardiovascular research, and to help promote further knowledge and understanding about the treatment of vascular disease in the Asian Pacific area. Nifedipine was originally investigated in the mid-1960s by Prof. Fleckenstein. His first results showed this drug was a powerful calcium antagonist which altered excitation contraction. At this time, there was a rapid development of knowledge about the pathophysiology of ischaemic heart disease, and thus the important pharmacological work on calcium antagonists such as nifedipine paralleled and complimented the newer understanding of coronary physiology in man. In a short time most therapy was designed to reduce myocardial oxygen consumption and demand.

More books from Springer Berlin Heidelberg

Cover of the book Intrinsic Immunity by
Cover of the book Modeling Risk Management for Resources and Environment in China by
Cover of the book Die Vermessung des Datenuniversums by
Cover of the book Pflegewissen Intermediate Care by
Cover of the book Onkologische Chirurgie bei alten Patienten by
Cover of the book Limit Theorems for Multi-Indexed Sums of Random Variables by
Cover of the book Endocrine Treatment of Breast Cancer by
Cover of the book Schizophrenia and Youth by
Cover of the book A Legal Guide to United States Business Organizations by
Cover of the book Homöopathie - die Fakten [unverdünnt] by
Cover of the book Computational Methods in Economic Dynamics by
Cover of the book Wie macht man Karriere in der Wissenschaft by
Cover of the book Managementwissen für Naturwissenschaftler und Ingenieure by
Cover of the book Methods of Clinical Epidemiology by
Cover of the book Olivocerebellar Projection by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy